Literature DB >> 11404481

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.

T Bowman1, M A Broome, D Sinibaldi, W Wharton, W J Pledger, J M Sedivy, R Irby, T Yeatman, S A Courtneidge, R Jove.   

Abstract

Signal transducer and activator of transcription (STAT) proteins perform key roles in mediating signaling by cytokines and growth factors, including platelet-derived growth factor (PDGF). In addition, Src family kinases activate STAT signaling and are required for PDGF-induced mitogenesis in normal cells. One STAT family member, Stat3, has been shown to have an essential role in cell transformation by the Src oncoprotein. However, the mechanisms by which STAT-signaling pathways contribute to mitogenesis and transformation are not fully defined. We show here that disruption of Stat3 signaling by using dominant-negative Stat3beta protein in NIH 3T3 fibroblasts suppresses c-Myc expression concomitant with inhibition of v-Src-induced transformation. Ectopic expression of c-Myc is able to partially reverse this inhibition, suggesting that c-Myc is a downstream effector of Stat3 signaling in v-Src transformation. Furthermore, c-myc gene knockout fibroblasts are refractory to transformation by v-Src, consistent with a requirement for c-Myc protein in v-Src transformation. In normal NIH 3T3 cells, disruption of Stat3 signaling with dominant-negative Stat3beta protein inhibits PDGF-induced mitogenesis in a manner that is reversed by ectopic c-Myc expression. Moreover, inhibition of Src family kinases with the pharmacologic agent, SU6656, blocks Stat3 activation by PDGF. These findings, combined together, delineate the signaling pathway, PDGF --> Src --> Stat3 --> Myc, that is important in normal PDGF-induced mitogenesis and subverted in Src transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404481      PMCID: PMC34666          DOI: 10.1073/pnas.131568898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen.

Authors:  M A Broome; S A Courtneidge
Journal:  Oncogene       Date:  2000-06-01       Impact factor: 9.867

2.  Identification of CDK4 as a target of c-MYC.

Authors:  H Hermeking; C Rago; M Schuhmacher; Q Li; J F Barrett; A J Obaya; B C O'Connell; M K Mateyak; W Tam; F Kohlhuber; C V Dang; J M Sedivy; D Eick; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.

Authors:  T Shirogane; T Fukada; J M Muller; D T Shima; M Hibi; T Hirano
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

Review 4.  STATs in oncogenesis.

Authors:  T Bowman; R Garcia; J Turkson; R Jove
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

5.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.

Authors:  H A Coller; C Grandori; P Tamayo; T Colbert; E S Lander; R N Eisenman; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

6.  Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.

Authors:  A J Kraker; B G Hartl; A M Amar; M R Barvian; H D Showalter; C W Moore
Journal:  Biochem Pharmacol       Date:  2000-10-01       Impact factor: 5.858

Review 7.  The role of STATs in transcriptional control and their impact on cellular function.

Authors:  J Bromberg; J E Darnell
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

8.  Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.

Authors:  Y Z Wang; W Wharton; R Garcia; A Kraker; R Jove; W J Pledger
Journal:  Oncogene       Date:  2000-04-20       Impact factor: 9.867

9.  Regulation of both apoptosis and cell survival by the v-Src oncoprotein.

Authors:  D Johnson; M Agochiya; K Samejima; W Earnshaw; M Frame; J Wyke
Journal:  Cell Death Differ       Date:  2000-08       Impact factor: 15.828

10.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

Authors:  J R Grandis; S D Drenning; Q Zeng; S C Watkins; M F Melhem; S Endo; D E Johnson; L Huang; Y He; J D Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

View more
  165 in total

Review 1.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

3.  Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Authors:  Ling-Yuan Kong; Adam S Wu; Tiffany Doucette; Jun Wei; Waldemar Priebe; Gregory N Fuller; Wei Qiao; Raymond Sawaya; Ganesh Rao; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2010-10-04       Impact factor: 12.531

4.  Absolute requirement for STAT3 function in small-intestine crypt stem cell survival.

Authors:  J R Matthews; O J Sansom; A R Clarke
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

Review 5.  Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.

Authors:  Ping Wan; Yongqing Hu; Li He
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

6.  Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer.

Authors:  Maria P De Miguel; Linzhao Cheng; Eric C Holland; Mark J Federspiel; Peter J Donovan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-24       Impact factor: 11.205

7.  RACK1 regulates G1/S progression by suppressing Src kinase activity.

Authors:  Vidya Mamidipudi; Jian Zhang; Kelly C Lee; Christine A Cartwright
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 9.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

10.  Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.

Authors:  Amir Sonnenblick; Carmit Levy; Ehud Razin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.